Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 31722-215

6 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 31722-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Daptomycinstructure (Daptomycinstructure)

Daptomycinstructure (Daptomycinstructure)
Chemical structure of daptomycin, shown as a detailed 2D molecular diagram with labeled atoms and bonds representing the cyclic lipopeptide antibiotic molecule.*
FDA Label Image
FDA Label Image
FDA Label Image

Daptomycincarton10sviallabel (Daptomycincarton10sviallabel)

Daptomycincarton10sviallabel (Daptomycincarton10sviallabel)
Packaging label for Daptomycin for Injection 350 mg per vial, lyophilized powder for intravenous use by Camber Pharmaceuticals, Inc. The label indicates it must be refrigerated, reconstituted with 7 mL of 0.9% sodium chloride injection to a final concentration of 50 mg/mL, and is for single-dose use only. The package contains 10 single-dose vials and includes handling instructions and manufacturer details, including Aspiro Pharma Limited, India.*
FDA Label Image

Daptomycin350mginnercarton (Daptomycin350mginnercarton)

Daptomycin350mginnercarton (Daptomycin350mginnercarton)
Packaging label for Daptomycin injection, powder, lyophilized, for solution, 350 mg per vial, by Camber Pharmaceuticals, Inc. The label includes reconstitution instructions with 7 mL of 0.9% sodium chloride to achieve 50 mg/mL concentration. It indicates the product must be refrigerated, is for intravenous use only, single-dose vial, and prescription use only. Manufactured by Aspiro Pharma Limited in India.*
FDA Label Image

Daptomycinviallabel (Daptomycinviallabel)

Daptomycinviallabel (Daptomycinviallabel)
Label for Daptomycin for Injection 350 mg per vial, lyophilized powder for IV solution by Camber Pharmaceuticals, Inc. Instructions include reconstitution with 7 mL 0.9% sodium chloride to 50 mg/mL, storage refrigerated at 2-8°C, and single-dose vial use. Manufactured by Aspiro Pharma Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.